ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 634724 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 634724; 2) Community: the network communities that were significantly associated with the response to NSC 634724; 3) Molecule: the relationships between components within communities and NSC 634724; 4) MDR: the compounds that were significantly associated with the NSC 634724.

NSC Compound Enrichment Correlation
NSC 681637 Camptothecin Derivative 0.000284051704014449 0.82916734
NSC 702759 Null 0.000284051704014449 -0.073117476
NSC 700023 Null 0.000288319947507353 -0.098341139
NSC 681636 Camptothecin Derivative 0.000374267341249421 0.83019177
NSC 681645 Camptothecin Derivative 0.000374267341249421 0.81113467
NSC 740618 (Z)-1-(2-chloro-5-(trifluoromethyl)phenyl)-4-(2-hydroxybenzylidene)-2-phenyl-1H-imidazol-5(4H)-one 0.000374267341249421 -0.012015333
NSC 609699 Topotecan hydrochloride 0.000395532514722381 0.89089408
NSC 644960 Null 0.000395532514722381 0.53317315
NSC 681639 Camptothecin Derivative 0.000395532514722381 0.82948661
NSC 706743 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione,6-[3-[(2-hydroxyethyl)amino]propyl]-2,3-dimethoxy- (9CI) 0.000395532514722381 0.76891571
Total:59  Current:2    [First] [Prev] [Next] [Last]